Updates are available Erratum dated 2022-09-01
Click to view Erratum: https://doi.org/10.1007/s13311-022-01286-9
-
Authors
Benatar, Michael
Wuu, Joanne
Andersen, Peter M.
Bucelli, Robert C.
Andrews, Jinsy A.
Otto, Markus
Farahany, Nita A.
Harrington, Elizabeth A.
Chen, Weiping
Mitchell, Adele A.
Ferguson, Toby
Chew, Sheena
Gedney, Liz
Oakley, Sue
Heo, Jeong
Chary, Sowmya
Fanning, Laura
Graham, Danielle
Sun, Peng
Liu, Yingying
Wong, Janice
Fradette, Stephanie
-
Funding
Funding for this research was provided by:
Biogen
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-022-01237-4
CrossRef DOI link to the associated document: https://doi.org/10.1007/s13311-022-01286-9
Content Type: article
Copyright: Copyright © 2022 The authors. Published by Elsevier B.V. All rights reserved.
